بررسی پیش‌آگهی بیماران ریوی براساس شاخص NLR

Christensen B, Favaloro EJ, Lippi G, Van Cott EM. Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost 2020t;46:845-9. doi: 10.1055/s-0040-1715458

Huang Z, Fu Z, Huang W, Huang K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. The American Journal of Emergency Medicine 2020;38:641-7. doi: 10.1016/j.ajem.2019.10.023

Tatum D, Taghavi S, Houghton A, Stover J, Toraih E, Duchesne J. Neutrophil-to-Lymphocyte Ratio and Outcomes in Louisiana COVID-19 Patients. Shock 2020;54:652-8. doi: 10.1097/SHK.0000000000001585

Kerboua KE. NLR: a cost-effective nomogram to guide therapeutic interventions in COVID-19. Immunological Investigations 2021;50:92-100. doi: 10.1080/08820139.2020.1773850

Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HH, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. Journal of Infection 2020;81:e6-e12. doi: 10.1016/j.jinf.2020.04.002

Islamoglu MS, Borku-Uysal B, Yavuzer S, Ikitimur H, Seyhan S, Koc S, Cengiz M. The Diagnostic and Predictive Roles of Neutrophil-Lymphocyte Ratio for Severity of Disease in COVID-19 Patients. Clin Lab 2021;67. doi: 10.7754/Clin.Lab.2021.210449.

Soytaş RB, Ünal D, Arman P, Suzan V, Gedik TE, Can G, et al. Factors affecting mortality in geriatric patients hospitalized with COVID-19. Turkish Journal of Medical Sciences 2021;51:454-63. doi: 10.3906/sag-2008-91

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases 2020;71:762-8. doi: 10.1093/cid/ciaa248

Nalbant A, Demirci T, Kaya T, Aydın A, Altındiş M, Güçlü E. Can prognostic nutritional index and systemic immune‐inflammatory index predict disease severity in COVID‐19? International Journal of Clinical Practice 2021;10:e14544. doi: 10.1111/ijcp.14544

Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology 2020;146:110-8. doi: 10.1016/j.jaci.2020.04.006

Jimeno S, Ventura PS, Castellano JM, García‐Adasme SI, Miranda M, Touza P, et al. Prognostic implications of neutrophil‐lymphocyte ratio in COVID‐19. European Journal of Clinical Investigation 2021;51:e13404. doi: 10.1111/eci.13404

Cataudella E, Giraffa CM, Di Marca S, Pulvirenti A, Alaimo S, Pisano M, et al. Neutrophil‐to‐lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community‐acquired pneumonia. Journal of the American Geriatrics Society 2017;65:1796-801. doi: 10.1111/jgs.14894

Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory coronavirus disease 2019 in Wuhan, China. Clinical Infectious Diseases 2021;73:e4208-e13. doi: 10.1093/cid/ciaa270

Kaya T, Yaylacı S, Nalbant A, Yıldırım İ, Kocayiğit H, Çokluk E, Şekeroğlu MR, Köroğlu M, Güçlü E. Serum calprotectin as a novel biomarker for severity of COVID-19 disease. Ir J Med Sci 2022;191:59-64. doi: 10.1007/s11845-021-02565-8

Ciccullo A, Borghetti A, Dal Verme LZ, Tosoni A, Lombardi F, Garcovich M, et al. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line. International Journal of Antimicrobial Agents 2020;56:106017-28. doi: 10.1016/j.ijantimicag.2020.106017

Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine 2020;58:1021-8. doi: 10.1515/cclm-2020-0369

Ghahramani S, Tabrizi R, Lankarani KB, Kashani SMA, Rezaei S, Zeidi N, et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. European Journal of Medical Research 2020;25:1-10. doi: 10.1186/s40001-020-00432-3